MedTrace Logo

to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve

NCT05007548 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-13

No results posted yet for this study

Summary

This is a phase 2 open-labeled study to compare the Ga68-Dolacga positron emission tomography with computer tomography volumetry and indocyanine green retention test for measurement of liver reserve among scheduled surgery operation patients.

Conditions

  • Hepatic Carcinoma

Interventions

DRUG

Ga68-Dolacga Injection

Ga68-Dolacga Injection, 2.0±1.0 mCi, single dose, iv bolus

Sponsors & Collaborators

  • National Atomic Research Institute, Taiwan

    lead OTHER

Principal Investigators

  • Wei-Chen Lee, MD · Linkon Chang Gung Memorial Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-14
Primary Completion
2023-11-20
Completion
2023-11-20
FDA Drug
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05007548 on ClinicalTrials.gov